Evidence map›Paper›PMID 29256515›Full record

ArticleNature chemistry2018

Bioinspired chemical synthesis of monomeric and dimeric stephacidin A congeners.

Ken Mukai, Danilo Pereira de Sant'Ana, Yasuo Hirooka, Eduardo V Mercado-Marin, David E Stephens, Kevin G M Kou, Sven C Richter, Naomi Kelley, Richmond Sarpong

Abstract read
In one paragraph

Article in Nature chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Skeletal Editing Strategies Driven by Total Synthesis.Accounts of chemical research · 2025
    Article
  3. Review
  4. Total synthesis of complex 2,5-diketopiperazine alkaloids.The Alkaloids. Chemistry and biology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ken MukaiDepartment of Chemistry, University of California, Berkeley, California 94720, USA.ORCID 0000-0002-8282-4876
Danilo Pereira de Sant'AnaDepartment of Chemistry, University of California, Berkeley, California 94720, USA.
Yasuo HirookaDepartment of Chemistry, University of California, Berkeley, California 94720, USA.ORCID 0000-0001-8574-5762
Eduardo V Mercado-MarinDepartment of Chemistry, University of California, Berkeley, California 94720, USA.ORCID 0000-0002-9775-6060
David E StephensDepartment of Chemistry, University of California, Berkeley, California 94720, USA.ORCID 0000-0002-8491-5931
Kevin G M KouDepartment of Chemistry, University of California, Berkeley, California 94720, USA.ORCID 0000-0002-4676-8846
Sven C RichterDepartment of Chemistry, University of California, Berkeley, California 94720, USA.ORCID 0000-0003-2848-7685
Naomi KelleyDepartment of Chemistry, University of California, Berkeley, California 94720, USA.ORCID 0000-0003-3875-2841
Richmond SarpongDepartment of Chemistry, University of California, Berkeley, California 94720, USA.ORCID 0000-0002-0028-6323

Funding

Proposal for Central California 900 MHZ NMR SpectrometerP41GM068933 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI WEMMER, DAVID E · 2003 to 2007
$5.9M
Total Synthesis of Bioactive Natural ProductsR01GM086374 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI SARPONG, RICHMOND · 2009 to 2018
$2.7M
600 MHz NMR Spectrometer for Solution-state NMRS10RR023679 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI ELLMAN, JONATHAN A · 2007 to 2007
$500k
A proposal for the purchase of a new Cu anode Microsource X-ray Diffractometer wiS10RR027172 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAYMOND, KENNETH N · 2010 to 2010
$500k
High Performance Computing Cluster for Public Health Driven Molecular Science - Core FacilityS10OD023532 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI DURKIN, KATHLEEN A · 2017 to 2017
$434k
NCRR NIH HHS S10 RR023679NCRR NIH HHS S10 RR027172NIGMS NIH HHS P41 GM068933NIGMS NIH HHS R01 GM086374NIH HHS S10 OD023532
6 · The paper itself

Abstract

Stephacidin A and its congeners are a collection of secondary metabolites that possess intriguing structural motifs. They stem from unusual biosynthetic sequences that lead to the incorporation of a prenyl or reverse-prenyl group into a bicyclo[2.2.2]diazaoctane framework, a chromene unit or the vestige thereof. To complement biosynthetic studies, which normally play a significant role in unveiling the biosynthetic pathways of natural products, here we demonstrate that chemical synthesis can provide important insights into biosynthesis. We identify a short total synthesis of congeners in the reverse-prenylated indole alkaloid family related to stephacidin A by taking advantage of a direct indole C6 halogenation of the related ketopremalbrancheamide. This novel strategic approach has now made possible the syntheses of several natural products, including malbrancheamides B and C, notoamides F, I and R, aspergamide B, and waikialoid A, which is a heterodimer of avrainvillamide and aspergamide B. Our approach to the preparation of these prenylated and reverse-prenylated indole alkaloids is bioinspired, and may also inform the as-yet undetermined biosynthesis of several congeners.

Indexed as

DimerizationBiological ProductsIndole AlkaloidsMolecular ConformationStereoisomerismBiological ProductsIndole Alkaloidsstephacidin A

Identifiers

PMID29256515
PMCPMC6317722

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.